284 related articles for article (PubMed ID: 31495642)
1. Cost Sharing and Utilization of Postpartum Intrauterine Devices and Contraceptive Implants Among Commercially Insured Women.
Moniz MH; Soliman AB; Kolenic GE; Tilea A; Fendrick AM; Bell S; Dalton VK
Womens Health Issues; 2019; 29(6):465-470. PubMed ID: 31495642
[TBL] [Abstract][Full Text] [Related]
2. Cost sharing, postpartum contraceptive use, and short interpregnancy interval rates among commercially insured women.
Moniz MH; Peahl AF; Fendrick AM; Kolenic GE; Tilea A; Wetmore M; Dalton VK
Am J Obstet Gynecol; 2021 Mar; 224(3):282.e1-282.e17. PubMed ID: 32898503
[TBL] [Abstract][Full Text] [Related]
3. The impact of out-of-pocket costs on the use of intrauterine contraception among women with employer-sponsored insurance.
Pace LE; Dusetzina SB; Fendrick AM; Keating NL; Dalton VK
Med Care; 2013 Nov; 51(11):959-63. PubMed ID: 24036995
[TBL] [Abstract][Full Text] [Related]
4. Factors Associated with New Uptake of Long-Acting Reversible Contraceptives Since the Affordable Care Act Among Privately Insured Women in Pennsylvania.
Nelson HN; Thayer E; Bailey C; Leuenberger L; Lehman E; Chuang CH
Womens Health Issues; 2019; 29(5):370-375. PubMed ID: 31337530
[TBL] [Abstract][Full Text] [Related]
5. The Impact of the Affordable Care Act on Contraceptive Use and Costs among Privately Insured Women.
Snyder AH; Weisman CS; Liu G; Leslie D; Chuang CH
Womens Health Issues; 2018; 28(3):219-223. PubMed ID: 29544988
[TBL] [Abstract][Full Text] [Related]
6. Factors associated with postpartum use of long-acting reversible contraception.
Oduyebo T; Zapata LB; Boutot ME; Tepper NK; Curtis KM; D'Angelo DV; Marchbanks PA; Whiteman MK
Am J Obstet Gynecol; 2019 Jul; 221(1):43.e1-43.e11. PubMed ID: 30885772
[TBL] [Abstract][Full Text] [Related]
7. The impact of cost sharing on women's use of annual examinations and effective contraception.
Dalton VK; Carlos RC; Kolenic GE; Moniz MH; Tilea A; Kobernik EK; Fendrick AM
Am J Obstet Gynecol; 2018 Jul; 219(1):93.e1-93.e13. PubMed ID: 29752935
[TBL] [Abstract][Full Text] [Related]
8. Six- and twelve-month documented removal rates among women electing postpartum inpatient compared to delayed or interval contraceptive implant insertions after Medicaid payment reform.
Crockett AH; Pickell LB; Heberlein EC; Billings DL; Mills B
Contraception; 2017 Jan; 95(1):71-76. PubMed ID: 27400823
[TBL] [Abstract][Full Text] [Related]
9. Implementing best practices for the provision of long-acting reversible contraception: a survey of obstetrician-gynecologists.
Castleberry NM; Stark L; Schulkin J; Grossman D
Contraception; 2019 Aug; 100(2):123-127. PubMed ID: 30981843
[TBL] [Abstract][Full Text] [Related]
10. Factors associated with short interpregnancy interval in women who plan postpartum LARC: a retrospective study.
Harney C; Dude A; Haider S
Contraception; 2017 Mar; 95(3):245-250. PubMed ID: 27589883
[TBL] [Abstract][Full Text] [Related]
11. Postpartum Contraceptive Use Among Denver-Based Adolescents and Young Adults: Association with Subsequent Repeat Delivery.
Harrison MS; Zucker R; Scarbro S; Sevick C; Sheeder J; Davidson AJ
J Pediatr Adolesc Gynecol; 2020 Aug; 33(4):393-397.e1. PubMed ID: 32251837
[TBL] [Abstract][Full Text] [Related]
12. Association of Medicaid Reimbursement Policies with Provision of Long-Acting Reversible Contraception in the Postpartum Period, 2012-2018.
Moon KJ; Chang LV; Bryant I; Hasenstab KA; Norris AH; Nawaz S
J Womens Health (Larchmt); 2024 May; 33(5):573-583. PubMed ID: 38488052
[No Abstract] [Full Text] [Related]
13. Inpatient Postpartum Long-Acting Reversible Contraception and Sterilization in the United States, 2008-2013.
Moniz MH; Chang T; Heisler M; Admon L; Gebremariam A; Dalton VK; Davis MM
Obstet Gynecol; 2017 Jun; 129(6):1078-1085. PubMed ID: 28486357
[TBL] [Abstract][Full Text] [Related]
14. Associations between immediate postpartum long-acting reversible contraception and short interpregnancy intervals.
Wu M; Eisenberg R; Negassa A; Levi E
Contraception; 2020 Dec; 102(6):409-413. PubMed ID: 32918870
[TBL] [Abstract][Full Text] [Related]
15. The relationship between long-acting reversible contraception and insurance coverage: a retrospective analysis.
Broecker J; Jurich J; Fuchs R
Contraception; 2016 Mar; 93(3):266-72. PubMed ID: 26577755
[TBL] [Abstract][Full Text] [Related]
16. Postpartum LARC discontinuation and short interval pregnancies among women with HIV: a retrospective 9-year cohort study in South Carolina.
Lazenby G; Francis E; Brzozowski N; Rucker L; Dempsey A
Contraception; 2019 Oct; 100(4):279-282. PubMed ID: 31226321
[TBL] [Abstract][Full Text] [Related]
17. Effect of staff training and cost support on provision of long-acting reversible contraception in community health centers.
Buckel C; Maddipati R; Goodman M; Peipert JF; Madden T
Contraception; 2019 Apr; 99(4):222-227. PubMed ID: 30685287
[TBL] [Abstract][Full Text] [Related]
18. Postpartum contraception: initiation and effectiveness in a large universal healthcare system.
Brunson MR; Klein DA; Olsen CH; Weir LF; Roberts TA
Am J Obstet Gynecol; 2017 Jul; 217(1):55.e1-55.e9. PubMed ID: 28257962
[TBL] [Abstract][Full Text] [Related]
19. Use of Immediate Postpartum Long-Acting Reversible Contraception Before and After a State Policy Mandated Inpatient Access.
Brant AR; Kollikonda S; Yao M; Mei L; Emery J
Obstet Gynecol; 2021 Nov; 138(5):732-737. PubMed ID: 34619694
[TBL] [Abstract][Full Text] [Related]
20. Postpartum long-acting reversible contraception among privately insured: U.S. National analysis 2007-2016, by term and preterm birth.
Shaw JG; Goldthwaite LM; Marić I; Shaw KA; Stevenson DK; Shaw GM
Contraception; 2023 Sep; 125():110065. PubMed ID: 37210023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
